Ofer Agid

9.4k total citations
135 papers, 5.9k citations indexed

About

Ofer Agid is a scholar working on Psychiatry and Mental health, Philosophy and Clinical Psychology. According to data from OpenAlex, Ofer Agid has authored 135 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Psychiatry and Mental health, 52 papers in Philosophy and 30 papers in Clinical Psychology. Recurrent topics in Ofer Agid's work include Schizophrenia research and treatment (106 papers), Mental Health and Psychiatry (52 papers) and Bipolar Disorder and Treatment (23 papers). Ofer Agid is often cited by papers focused on Schizophrenia research and treatment (106 papers), Mental Health and Psychiatry (52 papers) and Bipolar Disorder and Treatment (23 papers). Ofer Agid collaborates with scholars based in Canada, United States and Japan. Ofer Agid's co-authors include Gary Remington, George Foussias, Gagan Fervaha, Shitij Kapur, Robert B. Zipursky, Tamara Arenovich, Hiroyoshi Takeuchi, Bernard Lerer, Konstantine K. Zakzanis and Steven G. Potkin and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Ofer Agid

127 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ofer Agid 4.0k 1.2k 1.1k 1.1k 1.0k 135 5.9k
Jean‐Pierre Lindenmayer 5.2k 1.3× 1.7k 1.3× 1.5k 1.3× 1.1k 1.1× 1.1k 1.0× 134 6.9k
Robert Goldman 3.9k 1.0× 1.2k 0.9× 1.0k 0.9× 1.4k 1.3× 548 0.5× 100 5.4k
Raimo K. R. Salokangas 4.0k 1.0× 2.3k 1.8× 1.4k 1.3× 994 0.9× 893 0.9× 211 6.5k
Émmanuel Stip 4.6k 1.1× 1.6k 1.3× 943 0.9× 2.6k 2.4× 1.2k 1.2× 343 8.4k
Miquel Bernardo 5.5k 1.4× 1.5k 1.2× 844 0.8× 1.7k 1.6× 777 0.7× 406 8.8k
Larry Alphs 3.8k 1.0× 1.1k 0.9× 937 0.8× 584 0.5× 693 0.7× 174 5.2k
Antonio Vita 4.0k 1.0× 1.8k 1.5× 975 0.9× 2.5k 2.3× 905 0.9× 235 7.3k
Don Linszen 5.3k 1.3× 2.3k 1.8× 1.7k 1.6× 1.6k 1.4× 1.1k 1.0× 159 7.2k
Philippe Conus 5.3k 1.3× 2.4k 1.9× 1.0k 1.0× 854 0.8× 659 0.6× 307 8.5k
Gerhard Hellemann 4.0k 1.0× 2.3k 1.8× 963 0.9× 2.9k 2.7× 1.5k 1.4× 193 8.4k

Countries citing papers authored by Ofer Agid

Since Specialization
Citations

This map shows the geographic impact of Ofer Agid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Agid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Agid more than expected).

Fields of papers citing papers by Ofer Agid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Agid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Agid. The network helps show where Ofer Agid may publish in the future.

Co-authorship network of co-authors of Ofer Agid

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Agid. A scholar is included among the top collaborators of Ofer Agid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Agid. Ofer Agid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Procyshyn, Ric M., Martin A. Katzman, Howard C. Margolese, Ofer Agid, & Pierre Blier. (2025). Challenges for switching central nervous system and psychiatric medication products: A review of the literature. Journal of Psychopharmacology. 39(2). 81–91.
2.
Samara, Myrto, et al.. (2025). Current perspectives on the recognition and management of treatment-resistant schizophrenia: challenges and opportunities. Expert Review of Neurotherapeutics. 25(5). 505–519.
3.
Kane, John M., Ofer Agid, David Castle, et al.. (2025). The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment. Neurology and Therapy. 14(6). 2551–2581.
4.
5.
Davidson, Michael & Ofer Agid. (2023). Who has poor insight, my patient suffering from schizophrenia or myself?. European Neuropsychopharmacology. 68. 27–29. 2 indexed citations
6.
McIntyre, Roger S., et al.. (2023). Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. Neuroscience Applied. 2. 103498–103498. 1 indexed citations
7.
Agid, Ofer, et al.. (2021). Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective Study. The Canadian Journal of Psychiatry. 67(3). 226–234. 9 indexed citations
8.
Takeuchi, Hiroyoshi, Marcos Sanches, Carol Borlido, Ofer Agid, & Gary Remington. (2021). Antipsychotic nonadherence measured by electronic adherence monitoring in stabilized chronic schizophrenia: Clinical implications. Schizophrenia Research. 237. 202–207. 1 indexed citations
9.
Takeuchi, Hiroyoshi, Carol Borlido, Marcos Sanches, et al.. (2020). Adherence to clozapine vs. other antipsychotics in schizophrenia. Acta Psychiatrica Scandinavica. 142(2). 87–95. 25 indexed citations
10.
Potkin, Steven G., John M. Kane, Christoph U. Correll, et al.. (2020). The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. Schizophrenia. 6(1). 1–1. 245 indexed citations
11.
Kane, John M., Ofer Agid, Marjorie L. Baldwin, et al.. (2019). Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia. The Journal of Clinical Psychiatry. 80(2). 191 indexed citations
12.
Siddiqui, Ishraq, Ofer Agid, Zafiris J. Daskalakis, et al.. (2018). Reward-driven decision-making impairments in schizophrenia. Schizophrenia Research. 206. 277–283. 29 indexed citations
13.
Siddiqui, Ishraq, Gagan Fervaha, Konstantine K. Zakzanis, et al.. (2018). Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environment. Schizophrenia Research. 206. 400–406. 10 indexed citations
14.
Siddiqui, Ishraq, Gagan Fervaha, Ofer Agid, et al.. (2017). Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls. Psychiatry Research. 254. 112–117. 29 indexed citations
15.
Fervaha, Gagan, George Foussias, Hiroyoshi Takeuchi, Ofer Agid, & Gary Remington. (2015). Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being. Comprehensive Psychiatry. 66. 31–38. 30 indexed citations
16.
Mizrahi, Romina, Ofer Agid, Carol Borlido, et al.. (2011). Effects of antipsychotics on D3 receptors: A clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO. Schizophrenia Research. 131(1-3). 63–68. 71 indexed citations
17.
Agid, Ofer, George Foussias, & Gary Remington. (2010). Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention. Expert Opinion on Pharmacotherapy. 11(14). 2301–2317. 66 indexed citations
18.
Foussias, George, Steve Mann, Konstantine K. Zakzanis, et al.. (2010). MOTIVATIONAL DEFICITS IN SCHIZOPHRENIA: CROSS-SECTIONAL AND LONGITUDINAL RELATIONSHIPS WITH FUNCTIONING. Schizophrenia Research. 117(2-3). 303–304. 2 indexed citations
19.
Agid, Ofer & Bernard Lerer. (2003). Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin reuptake inhibitor and to triiodothyronine augmentation. The International Journal of Neuropsychopharmacology. 6(1). 41–49. 35 indexed citations
20.
Kohn, Yoav, Ofer Agid, Bella Hanin, et al.. (2001). Increased prevalence of negative life events in subtypes of major depressive disorder. Comprehensive Psychiatry. 42(1). 57–63. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Lindenmayer Breakdown of academic impact, for papers by Robert Goldman Breakdown of academic impact, for papers by Raimo K. R. Salokangas Breakdown of academic impact, for papers by Émmanuel Stip Breakdown of academic impact, for papers by Miquel Bernardo Breakdown of academic impact, for papers by Larry Alphs Breakdown of academic impact, for papers by Antonio Vita Breakdown of academic impact, for papers by Don Linszen Breakdown of academic impact, for papers by Philippe Conus Breakdown of academic impact, for papers by Gerhard Hellemann
Rankless by CCL
2026